How and why Toxoplasma makes us crazy

Trends in Parasitology

Volumn 29, Issue 4, 2013, Pages 156-163

  Flegr, Jaroslav ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Behavior; Manipulation hypothesis; Mental illness; Schizophrenia; Toxoplasma; Toxoplasmosis

Indexed keywords

DOPAMINE; TRYPTOPHAN;

DISEASE TRANSMISSION; HOST; NONHUMAN; PARASITOSIS; PREDATION; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SEXUALLY TRANSMITTED DISEASE; TOXOPLASMA; TOXOPLASMOSIS;

ACCIDENTS, OCCUPATIONAL; ACCIDENTS, TRAFFIC; ANIMALS; BEHAVIOR; BRAIN; CATS; DOPAMINE; FEMALE; HUMANS; MALE; MICE; PREGNANCY; RISK FACTORS; SCHIZOPHRENIA; SEXUALLY TRANSMITTED DISEASES; SUICIDE; TESTOSTERONE; TOXOPLASMA; TOXOPLASMOSIS; TRYPTOPHAN;

TOXOPLASMA;

EID: 84875488509     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2013.01.007     Document Type: Review

References (85)

1. Nicolle C., Manceaux L. Sur une infection à corps de Leishman (ou organismes voisins) du gondi. C. R. Seances Acad. Sci. (Paris) 1908, 147:763-766.
2. Torrey E.F., et al. Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr. Bull. 2007, 33:729-736.
3. Pearce B.D., et al. The relationship between Toxoplasma gondii infection and mood disorders in the Third National Health and Nutrition Survey. Biol. Psychiatry 2012, 72:290-295.
4. Hinze-Selch D., et al. The diagnosis of a personality disorder increases the likelihood for seropositivity to Toxoplasma gondii in psychiatric patients. Folia Parasitol. 2010, 57:129-135.
5. Miman O., et al. The probable relation between Toxoplasma gondii and Parkinson's disease. Neurosci. Lett. 2010, 475:129-131.
6. Kusbeci O.Y., et al. Could Toxoplasma gondii have any role in Alzheimer disease?. Alzheimer Dis. Assoc. Disord. 2011, 25:1-3.
7. Miman O., et al. Is there any role of Toxoplasma gondii in the etiology of obsessive-compulsive disorder?. Psychiatry Res. 2010, 177:263-265.
8. Yazar S., et al. Investigation of probable relationship between Toxoplasma gondii and cryptogenic epilepsy. Seiz. Eur. J. Epil. 2003, 12:107-109.
9. Koseoglu E., et al. Is Toxoplasma gondii a causal agent in migraine?. Am. J. Med. Sci. 2009, 338:120-122.
10. Prandota J. Autism spectrum disorders may be due to cerebral toxoplasmosis associated with chronic neuroinflammation causing persistent hypercytokinemia that resulted in an increased lipid peroxidation, oxidative stress, and depressed metabolism of endogenous and exogenous substances. Res. Autism Spectr. Disord. 2010, 4:119-155.
11. Niebuhr D.W., et al. Risk of schizophrenia and antibodies to Toxoplasma gondii among U.S. military personnel. Schizophr. Bull. 2007, 33:243-244.
12. Holub D., et al. Differences in onset of disease and severity of psychopathology between toxoplasmosis-related and toxoplasmosis-unrelated schizophrenia. Acta Psychiatr. Scand. 2013, 127:227-238.
13. Kodym P., et al. Toxoplasma in the Czech Republic 1923-1999: first case to widespread outbreak. Int. J. Parasitol. 2000, 30:11-18.
14. Horacek J., et al. Latent toxoplasmosis reduces gray matter density in schizophrenia but not in controls: voxel-based-morphometry (VBM) study. World J. Biol. Psychiatry 2012, 13:501-509.
15. Saha S., et al. A systematic review of the prevalence of schizophrenia. Schizophr. Res. 2006, 81:182-183.
16. Torrey E.F., et al. Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr. Bull. 2012, 38:642-647.
17. Zhou P., et al. Toxoplasma gondii infection in humans in China. Parasit. Vect. 2011, 4:165.
18. Hinze-Selch D., et al. A controlled prospective study of Toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalence. Schizophr. Bull. 2007, 33:782-788. erratum in 37, 652.
19. Lindová J., et al. Pattern of money allocation in experimental games supports the stress hypothesis of gender differences in Toxoplasma gondii-induced behavioural changes. Folia Parasitol. 2010, 57:136-142.
20. Lindová J., et al. Higher extraversion and lower conscientiousness in humans infected with Toxoplasma. Eur. J. Pers. 2012, 26:285-291.
21. Wang H.L., et al. Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia. Acta Psychiatr. Scand. 2006, 114:40-48.
22. Amminger G.P., et al. Antibodies to infectious agents in individuals at ultra-high risk for psychosis. Biol. Psychiatry 2007, 61:1215-1217.
23. Yolken R.H., et al. Toxoplasma and schizophrenia. Parasite Immunol. 2009, 31:706-715.
24. Willner P. The dopamine hypothesis of schizophrenia: current status, future prospects. Int. Clin. Psychopharmacol. 1997, 12:297-308.
25. Nikam S.S., Awasthi A.K. Evolution of schizophrenia drugs: a focus on dopaminergic systems. Curr. Opin. Investig. Drugs 2008, 9:37-46.
26. Stibbs H.H. Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Ann. Trop. Med. Parasitol. 1985, 79:153-157.
27. Skallová A., et al. Decreased level of novelty seeking in blood donors infected with Toxoplasma. Neuroendocrinol. Lett. 2005, 26:480-486.
28. Flegr J. Influence of latent Toxoplasma infection on human personality, physiology and morphology: pros and cons of the Toxoplasma-human model in studying the manipulation hypothesis. J. Exp. Biol. 2013, 216:127-133.
29. Hodková H., et al. Poorer results of mice with latent toxoplasmosis in learning tests: impaired learning processes or the novelty discrimination mechanism?. Parasitology 2007, 134:1329-1337.
30. Novotná M., et al. Probable neuroimmunological link between Toxoplasma and cytomegalovirus infections and personality changes in the human host. BMC Infect. Dis. 2005, 5:54.
31. Gaskell E.A., et al. A unique dual activity amino acid hydroxylase in Toxoplasma gondii. PLoS ONE 2009, 4:e4801.
32. Prandovszky E., et al. The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS ONE 2011, 6:e23866.
33. Fuks J.M., et al. GABAergic signaling is linked to a hypermigratory phenotype in dendritic cells infected by Toxoplasma gondii. PLoS Pathog. 2012, 8:e1003051.
34. Berenreiterova M., et al. The distribution of Toxoplasma gondii cysts in the brain of a mouse with latent toxoplasmosis: implications for the behavioral manipulation hypothesis. PLoS ONE 2011, 6:e28925.
35. McConkey G.A., et al. Toxoplasma gondii infection and behaviour - location, location, location?. J. Exp. Biol. 2013, 216:113-119.
36. Flegr J., et al. Sex-dependent toxoplasmosis-associated differences in testosterone concentration in humans. Parasitology 2008, 135:427-431.
37. Shirbazou S., et al. Effects of Toxoplasma gondii infection on plasma testosterone and cortisol level and stress index on patients referred to Sina hospital, Tehran. Jundishapur J. Microbiol. 2011, 4:167-173.
38. Kaňková Š., et al. Direct evidence of Toxoplasma-induced changes in serum testosterone in mice. Exp. Parasitol. 2011, 128:181-183.
39. Lim A., et al. Toxoplasma gondii infection enhances testicular steroidogenesis in rats. Mol. Ecol. 2013, 22:102-110.
40. Lindová J., et al. Gender differences in behavioural changes induced by latent toxoplasmosis. Int. J. Parasitol. 2006, 36:1485-1492.
41. Divanovic S., et al. Opposing biological functions of tryptophan catabolizing enzymes during intracellular infection. J. Infect. Dis. 2012, 205:152-161.
42. Nagineni C.N., et al. Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells. Infect. Immun. 1996, 64:4188-4196.
43. Silva N.M., et al. Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1. Infect. Immun. 2002, 70:859-868.
44. Hinze-Selch D., et al. A controlled prospective study of Toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalence. Schizophr. Bull. 2007, 33:782-788.
45. Schwarcz R., Hunter C.A. Toxoplasma gondii and schizophrenia: linkage through astrocyte-derived kynurenic acid?. Schizophr. Bull. 2007, 33:652-653.
46. Russo S., et al. Irritability rather than depression during interferon treatment is linked to increased tryptophan catabolism. Psychosom. Med. 2005, 67:773-777.
47. Arling T.A., et al. Toxoplasma gondii antibody titers and history of suicide attempts in patients with recurrent mood disorders. J. Nerv. Ment. Dis. 2009, 197:905-908.
48. Okusaga O., et al. Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia. Schizophr. Res. 2011, 133:150-155.
49. Yagmur F., et al. May Toxoplasma gondii increase suicide attempt - preliminary results in Turkish subjects?. Forensic Sci. Int. 2010, 199:15-17.
50. Lester D. Predicting European suicide rates with physiological indices. Psychol. Rep. 2010, 107:713-714.
51. Ling V.J., et al. Toxoplasma gondii seropositivity and suicide rates in women. J. Nerv. Ment. Dis. 2011, 199:440-444.
52. Pedersen M.G., et al. Toxoplasma gondii infection and self-directed violence in mothers. Arch. Gen. Psychiatry 2012, 69:1123-1130.
53. Flegr J., et al. Correlation of duration of latent Toxoplasma gondii infection with personality changes in women. Biol. Psychol. 2000, 53:57-68.
54. Havlíček J., et al. Decrease of psychomotor performance in subjects with latent 'asymptomatic' toxoplasmosis. Parasitology 2001, 122:515-520.
55. Thomas F., et al. Incidence of adult brain cancers is higher in countries where the protozoan parasite Toxoplasma gondii is common. Biol. Lett. 2012, 8:101-103.
56. Vittecoq M., et al. Brain cancer mortality rates increase with Toxoplasma gondii seroprevalence in France. Infect. Genet. Evol. 2012, 12:496-498.
57. Lester D. Toxoplasma gondii and homicide. Psychol. Rep. 2012, 111:196-197.
58. Barnard C.J., Behnke J.M. Parasitism and Host Behaviour 1990, Taylor and Francis.
59. Vyas A., Sapolsky R. Manipulation of host behaviour by Toxoplasma gondii: what is the minimum a proposed proximate mechanism should explain?. Folia Parasitol. 2010, 57:88-94.
60. Webster J.P., McConkey G.A. Toxoplasma gondii-altered host behaviour: clues as to mechanism of action. Folia Parasitol. 2010, 57:95-104.
61. Berdoy M., et al. Fatal attraction in rats infected with Toxoplasma gondii. Proc. R. Soc. Lond. B 2000, 267:1591-1594.
62. Vyas A., et al. Behavioral changes induced by Toxoplasma infection of rodents are highly specific to aversion of cat odors. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:6442-6447.
63. Flegr J., et al. Fatal attraction phenomenon in humans: cat odour attractiveness increased for Toxoplasma-infected men while decreased for infected women. PLoS Negl. Trop. Dis. 2011, 5:e1389.
64. Flegr J., et al. Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-control study. BMC Infect. Dis. 2002, 2:11.
65. Yereli K., et al. Is Toxoplasma gondii a potential risk for traffic accidents in Turkey?. Forensic Sci. Int. 2006, 163:34-37.
66. Kocazeybek B., et al. Higher prevalence of toxoplasmosis in victims of traffic accidents suggest increased risk of traffic accident in Toxoplasma-infected inhabitants of Istanbul and its suburbs. Forensic Sci. Int. 2009, 187:103-108.
67. Flegr J., et al. Increased incidence of traffic accidents in Toxoplasma-infected military drivers and protective effect RhD molecule revealed by a large-scale prospective cohort study. BMC Infect. Dis. 2009, 9:72.
68. Alvarado-Esquivel C., et al. High seroprevalence of Toxoplasma gondii infection in a subset of Mexican patients with work accidents and low socioeconomic status. Parasit. Vect. 2012, 5:13.
69. Hove T., Mukaratirwa S. Seroprevalence of Toxoplasma gondii in farm-reared ostriches and wild game species from Zimbabwe. Acta Trop. 2005, 94:49-53.
70. Kaňková Š., et al. Women infected with parasite Toxoplasma have more sons. Naturwissenschaften 2007, 94:122-127.
71. Kaňková Š., et al. Influence of latent toxoplasmosis on the secondary sex ratio in mice. Parasitology 2007, 134:1709-1717.
72. Hostomská L., et al. Mongolismus und latente Toxoplasmosis der Mutter. Endokrinologie 1957, 34:295-304.
73. Kaňková Š., Flegr J. Longer pregnancy and slower fetal development in women with latent 'asymptomatic' toxoplasmosis. BMC Infect. Dis. 2007, 7:114.
74. Kankova S., et al. Slower postnatal motor development in infants of mothers with latent toxoplasmosis during the first 18 months of life. Early Hum. Dev. 2012, 88:879-884.
75. Neuhauser M., Krackow S. Adaptive-filtering of trisomy 21: risk of Down syndrome depends on family size and age of previous child. Naturwissenschaften 2007, 94:117-121.
76. Zimmermann S., et al. Induction of suppressor of cytokine signaling-1 by Toxoplasma gondii contributes to immune evasion in macrophages by blocking IFN-gamma signaling. J. Immunol. 2006, 176:1840-1847.
77. Flegr J., Stříž I. Potential immunomodulatory effects of latent toxoplasmosis in humans. BMC Infect. Dis. 2011, 11:274.
78. Handley L.J.L., Perrin N. Advances in our understanding of mammalian sex-biased dispersal. Mol. Ecol. 2007, 16:1559-1578.
79. Kramer W. Frontiers of neurological diagnosis in acquired toxoplasmosis. Psychiatr. Neurol. Neurochir. 1966, 69:43-64.
80. Dubey J.P. Toxoplasmosis - a waterborne zoonosis. Vet. Parasitol. 2004, 126:57-72.
81. Anand R., et al. Acute primary toxoplasmosis in travelers returning from endemic countries. J. Travel Med. 2012, 19:57-60.
82. Dass S.A.H., et al. Protozoan parasite Toxoplasma gondii manipulates mate choice in rats by enhancing attractiveness of males. PLoS ONE 2011, 6:e27229.
83. Boyer K.M., et al. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: implications for prenatal management and screening. Am. J. Obstet. Gynecol. 2005, 192:564-571.
84. Petersen E., et al. What do we know about risk factors for infection in humans with Toxoplasma gondii and how can we prevent infections?. Zoonoses Public Health 2010, 57:8-17.
85. Flegr J. Influence of latent toxoplasmosis on the phenotype of intermediate hosts. Folia Parasitol. 2010, 57:81-87.